Stifel Reiterates Buy Rating on Cytokinetics (CYTK)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Wall St futures climb as AI stocks rebound; oil, yields fall
- Oil slips from five-month high with Hormuz transits in focus
- Stay risk-off as higher real yields and AI volatility threaten stocks: BofA
- Apple’s first foldable iPhone sells out within minutes as preorders begin
- CoreWeave bond rout tests market's math on AI buildout
| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 61.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.95 | 52 Week High | $13.18 | |||
| Open | $61.95 | 52 Week Low | $6.00 | |||
| Day High | $61.95 | P/E | N/A | |||
| Day Low | $61.95 | EPS | $-1.24 | |||
| Volume | 6,260 | |||||
